Abstract:Lung diseases have complex pathogenesis and treatment challenges, showing an obvious increase in the rate of diagnosis and death every year. Therefore, elucidating the mechanism for their pathogenesis and treatment ineffective from novel views is essential and urgent. Methyltransferase-like 3 (METTL3) is a novel post-transcriptional regulator for gene expression that has been implicated in regulating lung diseases, including that observed in chronic conditions such as pulmonary fibrosis (PF), pulmonary arterial hypertension (PAH), and chronic obstructive pulmonary disease (COPD), as well as acute conditions such as pneumonia, severe acute respiratory syndrome coronavirus 2 infection, and sepsis-induced acute respiratory distress syndrome. Notably, a comprehensive summary and analysis of findings from these studies might help understand lung diseases from the novel view of METTL3-regulated mechanism, however, such a review is still lacking. Therefore, this review aims to bridge such shortage by summarising the roles of METTL3 in lung diseases, establishing their interrelationships, and elucidating the potential applications of METTL3 regarding diagnosis, treatment, and prognosis. The analysis collectively suggests METTL3 is contributable to the onset and progression of these lung diseases, thereby prospecting METTL3 as a valuable biomarker for their diagnosis, treatment, and prognosis. In conclusion, this review offers elucidation into the correlation between METTL3 and lung diseases in both research and clinical settings and highlights potential avenues for exploring the roles of METTL3 in the respiratory system.

The indispensability of methyltransferase-like 3 in the immune system: from maintaining homeostasis to driving function

METTL3 plays a crucial function in multiple biological processes

Methyltransferase-like 3 Modifications of RNAs: Implications for the Pathology in the Endocrine System.

Methyltransferase-like 3 Mediated RNA M6 A Modifications in the Reproductive System: Potentials for Diagnosis and Therapy.

Regulatory Network of Methyltransferase-Like 3 in Stem Cells: Mechanisms and Medical Implications

Methyltransferase‐like 3 mediated RNA m6A modifications in the reproductive system: Potentials for diagnosis and therapy

Multiple functions and mechanisms underlying the role of METTL3 in human cancers

Methyltransferase-like 3 mediated RNA m<SUP>6</SUP>A modifications in the reproductive system: Potentials for diagnosis and therapy

Mettl3-dependent M6a Modification is Essential for Effector Differentiation and Memory Formation of CD8+ T Cells.

The RNA m6A writer METTL3 in tumor microenvironment: emerging roles and therapeutic implications

The Role of RNA Methyltransferase METTL3 in Normal and Malignant Hematopoiesis

The Regulatory Network of METTL3 in the Nervous System: Diagnostic Biomarkers and Therapeutic Targets.

Understanding how methyltransferase-like 3 functions in lung diseases: From pathogenesis to clinical application

Roles of METTL3 in Cancer: Mechanisms and Therapeutic Targeting

Methyltransferase-like 3 Promotes Cervical Cancer Metastasis by Enhancing Cathepsin L Mrna Stability in an N6-methyladenosine-dependent Manner

Emerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications

Diagnostic and therapeutic potentials of methyltransferase-like 3 in liver diseases

Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells

The Role of Protein Methyltransferases in Immunity

The Development of Small Molecules Targeting Methyltransferase-Like 3

METTL3-dependent m6A modification programs T follicular helper cell differentiation